
Sara Tolaney, MD, MPH, Dana-Farber Harvard Cancer Center
Advertisement
Articles by Sara Tolaney, MD, MPH, Dana-Farber Harvard Cancer Center
Advertisement
Latest Updated Articles
Perioperative Therapy: ASCO 2020 Data UpdatesAugust 13th 2020
Metastatic HR+ Breast Cancer UpdatesAugust 13th 2020
Metastatic Triple-Negative Breast Cancer Ongoing TrialsAugust 13th 2020
ASCO 2020 Data Updates: Metastatic HER2+ Breast CancerAugust 13th 2020
Advertisement
Advertisement
Trending on OncLive
1
CLL Treatment Individualization Prompts Changes in Patient Evaluation and Care
2
Japan Approves Subcutaneous Pembrolizumab for All Approved Pembrolizumab Indications
3
FDA Grants Fast Track Designation to LYT-200 in R/R High-Risk MDS
4
Integrating Bispecific Antibodies Into Frontline Therapy for Newly Diagnosed Multiple Myeloma
5



